(Q38119225)

29 August 2017

Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis (English)

1 reference

29 August 2017

1 reference

1 reference

Seyed-Moayed Alavian

1

1 reference

29 August 2017

Seyed Vahid Tabatabaei

series ordinal

2

1 reference

29 August 2017

Bita Behnava

series ordinal

3

1 reference

29 August 2017

Mario Rizzetto

series ordinal

4

1 reference

29 August 2017

1 October 2012

1 reference

Journal of Research in Medical Sciences

29 August 2017

1 reference

29 August 2017

17

1 reference

29 August 2017

10

1 reference

29 August 2017

967-974

1 reference

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

29 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Alpha interferon and ribavirin combination therapy of chronic hepatitis D.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Measuring inconsistency in meta-analyses

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Hepatitis delta: the virus and the disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Therapy of chronic delta hepatitis with interferon alfa-2b

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Interferon therapy of chronic delta hepatitis in patients cured of pediatric malignancies: possible harmful effect

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Treatment of chronic type D hepatitis and concomitant human immunodeficiency infection with alpha-interferon

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

31 August 2018

HDV: thirty years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Two-year interferon therapy with or without ribavirin in chronic delta hepatitis

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Alpha-interferon treatment in HBeAg positive children with chronic hepatitis B and associated hepatitis D.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698658

Therapy of chronic delta hepatitis with alpha- and beta-interferon

3 December 2018

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of chronic delta hepatitis with recombinant human alpha interferon

1 reference

12 December 2020

Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction

1 reference

12 December 2020

Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis

1 reference

12 December 2020

[Treatment of chronic delta hepatitis with recombinant alpha 2 interferon in 8 patients with anti-human immunodeficiency virus antibodies]

1 reference

12 December 2020

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

1 reference

12 December 2020

Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study

1 reference

12 December 2020

Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children

1 reference

12 December 2020

Long term interferon treatment of chronic delta hepatitis: a multicenter Italian study

1 reference

12 December 2020

Adefovir dipivoxyl for the treatment of delta-related liver cirrhosis

1 reference

12 December 2020

Treatment outcome in patients of hepatitis B with hepatitis D: experience of 4 years at a tertiary care centre in Pakistan

1 reference

12 December 2020

Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study

1 reference

12 December 2020

Peginterferon plus adefovir versus either drug alone for hepatitis delta

1 reference

12 December 2020

Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses

1 reference

12 December 2020

Alpha interferon therapy of chronic delta hepatitis: a pilot study

1 reference

12 December 2020

A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study

1 reference

12 December 2020

Treatment of patients with delta hepatitis using interferon

1 reference

12 December 2020

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

12 December 2020

Interferon and delta hepatitis

1 reference

12 December 2020

[The clinico-morphological characteristics and efficacy of interferon therapy in patients with chronic delta hepatitis]

1 reference

12 December 2020

Successful Treatment of Chronic Hepatitis D with a Short Course of Peginterferon alfa-2a

1 reference

12 December 2020

Identifiers

1 reference

29 August 2017

PubMed publication ID

23825999

1 reference